Calibration-free pulse oximetry
Summary
The USPTO granted Patent US12588841B2 to Viavi Solutions Inc. on March 31, 2026, covering calibration-free pulse oximetry devices and methods. The patent (20 claims) describes devices and methods for calculating arterial oxygen saturation using photoplethysmography (PPG) data analysis without requiring traditional calibration. Inventors: Lan Sun, Chang Meng Hsiung, Babs Soller.
What changed
The USPTO granted Patent US12588841B2 to Viavi Solutions Inc. on March 31, 2026, for calibration-free pulse oximetry technology. The patent covers devices that identify peak and trough timestamps from PPG data, generate absorption spectra, and calculate arterial oxygen saturation by fitting an arterial blood spectrum model to measured data. The patent contains 20 claims and names Lan Sun, Chang Meng Hsiung, and Babs Soller as inventors.
This is a routine patent grant creating no new regulatory obligations. Medical device manufacturers and healthcare technology companies developing pulse oximetry products should review the patent claims to assess potential infringement risks andFreedom-to-operate implications for competing or complementary products.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Calibration-free pulse oximetry
Grant US12588841B2 Kind: B2 Mar 31, 2026
Assignee
VIAVI SOLUTIONS INC.
Inventors
Lan Sun, Chang Meng Hsiung, Babs Soller
Abstract
A device may identify a peak timestamp and a trough timestamp based on a first principal component of photoplethysmography (PPG) data associated with a plurality of wavelength channels. The device may generate a peak absorption spectrum based on the peak timestamp and the PPG data, and may generate a trough absorption spectrum based on the trough timestamp and the PPG data. The device may determine a measured arterial blood spectrum based on the peak absorption spectrum and the trough absorption spectrum. The device may fit the arterial blood spectrum model to the measured arterial blood spectrum to determine a set of values, each value in the set of values corresponding to a variable in a set of variables. The device may calculate an arterial oxygen saturation value based on one or more values of the set of values.
CPC Classifications
A61B 5/14552 A61B 5/02427
Filing Date
2022-04-29
Application No.
17661306
Claims
20
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.